Información del producto
4-Sulfamoyl-phenylacetic acid (SPAA) is a potent and selective Cox-2 inhibitor. SPAA has been found to inhibit the polymerase activity of the virus, leading to apoptosis. This drug also inhibits the COX-2 enzyme and prevents the formation of prostaglandins, which are inflammatory mediators. SPAA has shown inhibitory activities against prostate cancer cells and may be effective in treating prostate cancer. SPAA also inhibits COX-2 enzyme activity in human prostate cancer cells, suggesting that it may be useful for preventing metastasis.
Propiedades químicas
Consulta técnica sobre: 3D-XAA95864 (4-Sulfamoyl-phenyl)-acetic acid
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
